This protocol applies to the syndromic form of dominant optic atrophy (DOA) presenting with concurrent sensorineural hearing loss (neurosensorial deafness) — a distinct sub-population in whom audiological impairment is part of the syndromic picture and requires targeted intervention.
Management of the hearing component in this syndromic presentation involves a device-based auditory intervention. The full structured protocol specifies the indication criteria, patient selection considerations, and the complete evidence-based regimen — details available via the link below.
The primary clinical target is marked improvement of audition, directly addressing the sensorineural hearing loss associated with this syndromic form of dominant optic atrophy.
DOI: 10.1186/1750-1172-7-46
Cochlear implants have been shown to restore a marked improved audition in patients with syndromic DOA with neurosensorial deafness.
View source ↗